Bavarian Nordic in new vaccine contract

Bavarian Nordic A/S has received another vaccine contract from the US government, this time to develop candidate vaccine components and technologies for a combined smallpox and Marburg virus vaccine using the company’s vector technology.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Denmark